Vicarious Surgical (RBOT) Free Cash Flow (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Free Cash Flow came in at -$10.6 million in Q3 2025, up 16.07% year-over-year from -$9.1 million in Q3 2024, and up 21.51% quarter-over-quarter from -$13.5 million in Q2 2025.
Analysis
Vicarious Surgical (RBOT) Free Cash Flow (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Free Cash Flow for 6 consecutive years, with -$10.6 million the latest figure, recorded in Q3 2025.
- On a quarterly basis, Free Cash Flow rose 16.07% year-over-year to -$10.6 million in Q3 2025; TTM through Sep 2025 was -$47.9 million, a 5.29% increase from a year earlier, with the FY2024 full-year figure at -$50.1 million, up 21.63% from the prior year.
- Free Cash Flow was -$10.6 million for Q3 2025 at Vicarious Surgical, up from -$13.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$4.3 million in Q1 2021 and troughed at -$19.4 million in Q4 2022.
- A 5-year average of -$13.2 million and a median of -$13.5 million in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 3845.99% in 2021 and jumped 36.04% in 2023, its largest moves.
- Over 5 years, Free Cash Flow stood at -$10.6 million in 2021, then slumped by 82.68% to -$19.4 million in 2022, then jumped by 36.04% to -$12.4 million in 2023, then advanced by 3.34% to -$12.0 million in 2024, then increased by 11.5% to -$10.6 million in 2025.
- The last three Free Cash Flow figures came in at -$10.6 million (Q3 2025), -$13.5 million (Q2 2025), and -$11.8 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 948.40 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.29 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.06 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.28 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 585.00 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 606.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 184.50 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -10.61 Mn |
| Jun 30, 2025 | -13.52 Mn |
| Mar 31, 2025 | -11.75 Mn |
| Dec 31, 2024 | -11.99 Mn |
| Sep 30, 2024 | -12.65 Mn |
| Jun 30, 2024 | -11.03 Mn |
| Mar 31, 2024 | -14.47 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Sep 30, 2023 | -17.40 Mn |
| Jun 30, 2023 | -15.29 Mn |
| Mar 31, 2023 | -18.88 Mn |
| Dec 31, 2022 | -19.40 Mn |
| Sep 30, 2022 | -14.62 Mn |
| Jun 30, 2022 | -15.76 Mn |
| Mar 31, 2022 | -16.79 Mn |
| Dec 31, 2021 | -10.62 Mn |
| Sep 30, 2021 | -13.72 Mn |
| Jun 30, 2021 | -5.98 Mn |
| Mar 31, 2021 | -4.27 Mn |
| Dec 31, 2020 | -482,301.00 |